Open-label Study of APX001 for Treatment of Patients With Invasive Mold

See also
Status	Clinical Trial	Phase
Completed	`NCT05749380` - Pharmacokinetics and Safety of AmBisome and DKF-5122	Phase 1
Not yet recruiting	`NCT02527928` - Cost-Effectiveness of Amphotericin B	N/A
Completed	`NCT02851680` - Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.	N/A
Completed	`NCT03572049` - Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole	Phase 2/Phase 3
Suspended	`NCT05534529` - Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age	Phase 1
Completed	`NCT04024995` - Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
Completed	`NCT00745992` - Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
Completed	`NCT06413056` - Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection	Phase 4
Recruiting	`NCT05130723` - Pharmacokinetics of Fluconazole in Children (2-18 Years)
Recruiting	`NCT04157465` - Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients	N/A
Completed	`NCT04122560` - Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration	Phase 4
Completed	`NCT03262584` - Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Completed	`NCT02678598` - A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections	N/A
Completed	`NCT05491733` - A Bioequivalence Study of APX001 High-load and Low-load Tablets	Phase 1
Not yet recruiting	`NCT06220370` - PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
Completed	`NCT04777058` - Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit
Recruiting	`NCT03583164` - Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options	Phase 2
Completed	`NCT03174457` - Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
Completed	`NCT00750737` - Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)	Phase 3
Not yet recruiting	`NCT06346951` - Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)

NCT number	NCT04240886
Study type	Interventional
Source	Basilea Pharmaceutica
Contact
Status	Terminated
Phase	Phase 2
Start date	January 4, 2020
Completion date	May 9, 2022

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds — AEGIS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms